Научная литература
booksshare.net -> Добавить материал -> Медицина -> Джордж А.Г. -> "Анестезия и педиатрия" -> 583

Анестезия и педиатрия - Джордж А.Г.

Джордж А.Г. Анестезия и педиатрия — М.: Медицина, 2003. — 1192 c.
ISBN 5-225-03821-2
Скачать (прямая ссылка): anesteziyavpedeatrii2003.djvu
Предыдущая << 1 .. 577 578 579 580 581 582 < 583 > 584 585 586 587 588 589 .. 1012 >> Следующая

19. CaspiJ, Coles JC, Benson LN et al: Effects of high plasma epinephrine end Ca2+ concentrations on neonatal myocardial function after ischemia. J Thorac Cardiovasc Surg 105:59, 1993
20. Caspi J, Coles JC, Benson LN et al: Age-related response to epinephrine-induced myocardial stress. A functional and ultrastructural study. Circulation 84, suppl. 111:111394,
1991
21. Robinson BW, Gelband H, Mas MS. Selective pulmonary and systemic vasodilator effects of amrinone in children: new therapeutic implications. J Am Coll Cardiol 21:1461, 1993
22. Berner M, Jaccard C, Oberhansii i: Hemodynamic effects of amrinone in children after cardiac surgery. Intensive Care Med 16:85, 1990
23. Cheng AC, Atz AM, Wemovsky C, et al: Milrinone: systemic and pulmonary hemodynamic effects in neonates after cardiac surgery. Crit Care Med 23:1907, 1995
24. Dupuis JY, Bondy R, Cattran С et al: Amrinone end do* butamine as primary treatment of low cardiac output syndrome following coronary artery surgery, a comparisonof their effects on hemodynamics and outcome. J Cardiothorac Vase Anesth 6:542, 1992
25. Bailey JM, Miller BE, Lu W, et al: The phermacokinetics of milrinone in pediatric patients after cardiac surgery. Anesthesiology 90:1012, 1999
26. Ramamoorthy C, Aoderson CD, Wiliams CD, Lynn AM: Pharmacokinetics and side effects of milrinone in in* fanes and children after open heart surgery. Anasth Analg 86:283, 1998
27. Sluysmans T, Styns-Cailteux M, Tremouroux-Wattiez M el al: Intravenous enalaprilat and oral enalapril in congestive heart failure secondary to ventricular septal defect in infancy. Am J Cardiol 70:959, 1992
28. Hoffman JlE, Rudolph AM, Heymann MA: Pulmonary vascular disease with congenital heart lesions: Pathologic features and causes. Circulation 64:873, 1981
29. Heath D, Edwards J E: The pathology of hypertensive pulmonary vascular disease. Circulation 28:533, 1958
30. Clapp S, Perry BL, Farooki ZQ et al: Down’s syndrome, complete atrioventricular canal, and pulmonary vascular obstructive disease. J Thorac Cardiovasc Suig 100:115, 1990
31. Del Nido PJ, Williams WG, Villamater J et al: Changes in pericardial surface pressure during pulmonary hypertensive crises after cardiac suigery. Circulation 76, suppl
ІІІ.Ш93, 1987
32. Hickey PR, Hansen DD. Pulmonary hypertension in infants: postoperative management, p. 16. In Yacoub M (ed): Annual of Cardiac Surgery. Current Science, London, 1989
33. Wheller J, George BL, Mulder DC, Jarmakani JM: Diagnosis and management of postoperative pulmonary hypertensive crisis. Circulation 70:1640, 1979
34. Jones ODH, Shore DF, Rigby ML et al: The use of tola-zoline hydrochloride as a pulmonary vasodilator in potentially fetal episodes of pulmonary vasoconstriction after cardiac suigery in children. Circulation 64:134, 1981
35. Drummond WH, Gregory GA, Heymann MA, Phibbs
Анестезия при врожденных заболеваниях сердца 685
RA: The independent effects of hyperventilation, tolazo-line, and dopamine on infants with persistent pulmonary hypertension. J Pediatr 98:603, 1981
36. Bush A, Busst C, Knight WB, Shineboume EA: Modification of pulmonary hypertension secondary to congenital heart disease by prostacyclin therapy. Am Rev Respir Dis 136:767, 1987
37. Bush A, Busst C, Booth K: Does prostacyclin enhance the selective pulmonary vasodilator effect of oxygen in children with congenital heart disease. Circulation 74:135,
1986
38. Kirklin JW, Barratt-Boyes BG: Hypothermia, circulatory arrest, and cardiopulmonary bypass, p. 29. In: Cardiac Surgery. Wiley Medical, New York, 1986
39. Meyrick B, Reid L: Ultrastructural findings in lung biopsy material from children with congenital heart defects. Am J Pathol 101:527, 1980
40. Koul B, Willen H, SjobeigT et al: Pulmonary sequelae of prolonged total venoarterial bypass: evaluation with a new experimental model. Ann Thorac Suig 51:794, 1991
41. Koul B, Wollmer P, Willen H et al: Venoarterial extracor-poreal membrane oxygenation — how sate is it? J Thorac Cardiovasc Suig 104:579, 1992
42. Furchgott RF: The role of endothelium in the responses of vascular smooth muscle to drugs. Annu Rev Pharmacol Toxicol 24:175, 1984
43. Furchgott RF, Zawadzki JV: The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature 288:373, 1980
44. Fulmer RJM, Ferrige AG, Moncada S: Nitric oxide release accounts for the biologic nctivity of endothelium-derived relaxing factor. Nature 327:524, 1907
45. Ignarro LJ, Biiga GM, Woods KS et al: Endothelium-derived relaxing factor produced and released from artery and vein is nitric oxide. Proc Natl Acad Sci USA 84:9265,
1987
46. Ignarro LJ, Harbison RG, Wood KS, Kndowitz PJ: Activation of purified soluble guanylate cyclase by endothelium-derived relaxing factor from intrapolmonary artery and vein: stimulation by acetylcholine, bradykinin and araehidonic acid. J Pharmacol Exp Ther 237:893, 1986
47. Wessel DL, Adatia 1, Giglia TM, et al: Use of inhaled nitric oxide and acetylcholine in the evaluation of pulmonary hypertension and endothelial function after cardiopulmonary bypass. Circulation 88:2128, 1993
Предыдущая << 1 .. 577 578 579 580 581 582 < 583 > 584 585 586 587 588 589 .. 1012 >> Следующая

Реклама

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed

Есть, чем поделиться? Отправьте
материал
нам
Авторские права © 2009 BooksShare.
Все права защищены.
Rambler's Top100

c1c0fc952cf0704ad12d6af2ad3bf47e03017fed